Page 107 - Genomic Medicine in Emerging Economies
P. 107
96 CHAPTER 5: Screening for Hereditary Cancer in Latin America
Hall, J.M., Lee, M.K., Newman, B., Morrow, J.E., Anderson, L.A., Huey, L.A., et al., 1990. Linkage
of early-onset familial breast cancer to chromosome 17q21. Science (80) 250, 1684–1689.
Hamel, N., Feng, B.-J., Foretova, L., Stoppa-Lyonnet, D., Narod, S.A., Imyanitov, E., et al., 2011. On
the origin and diffusion of BRCA1 c 5266dupC (5382insC) in European populations. Eur. J.
Hum. Genet. 19 (3), 300–306.
Hampel, H., Frankel, W.L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., et al., 2005. Screen-
ing for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N. Engl. J. Med. 352
(18), 1851–1860.
Hampel, H., Frankel, W., Panescu, J., Lockman, J., Sotamaa, K., Fix, D., et al., 2006. Screening
for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer
patients. Cancer Res. 66 (15), 7810–7817.
He, T., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., Costa, L.T., et al., 1998. Identification of
c- MYC as a target of the APC pathway. Science (80) 281, 1509–1512.
Hernández, J.E.L., Llacuachaqui, M., Palacio, G.V., Figueroa, J.D., Madrid, J., Lema, M., et al., 2014.
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín
Colombia. Hered. Cancer Clin. Pract. 12 (1), 11.
Howlader, N., Noone, A.M., Krapcho, M., et al., 2016. SEER cancer statistics review, 1975–2013. In:
National Cancer Institute Bethesda, MD.
Jara, L., Ampuero, S., Santibáñez, E., Seccia, L., Rodríguez, J., Bustamante, M., et al., 2006. BRCA1 and
BRCA2 mutations in a South American population. Cancer Genet. Cytogenet. 166 (1), 36–45.
Kinzler, K., Nilbert, M., Su, L., Vogelstein, B., Bryan, T., Levy, D., et al., 1991. Identification of FAP
locus genes from chromosome 5q21. Science (80) 253 (5020), 661–665.
Knudsen, A.L., Bisgaard, M.L., Bülow, S., 2003. Attenuated familial adenomatous polyposis
(AFAP). A review of the literature. Familial Cancer 2, 43–55.
Kobayashi, H., Ohno, S., Sasaki, Y., Matsuura, M., 2013. Hereditary breast and ovarian cancer sus-
ceptibility genes (Review). Oncol. Rep. 30, 1019–1029.
Koehler-Santos, P., Izetti, P., Abud, J., Pitroski, C.E., Cossio, S.L., Camey, S.A., et al., 2011. Iden-
tification of patients at-risk for lynch syndrome in a hospital-based colorectal surgery clinic.
World J. Gastroenterol. 17 (6), 766–773.
Lara, K., Consigliere, N., Pérez, J., Porco, A., 2012. BRCA1 and BRCA2 mutations in breast cancer
patients from Venezuela. Biol. Res. 45 (2), 117–130.
Leite, S.M.O., Gomes, K.B., Pardini, V.C., Ferreira, A.C.S., Oliveira, V.C., Cruz, G.M.G., 2010. Assess-
ment of microsatellite instability in colorectal cancer patients from Brazil. Mol. Biol. Rep. 37
(1), 375–380.
Leppert, M., Dobbs, M., Scambler, P., O’Connell, P., Nakamura, Y., Stauffer, D., et al., 1987. The
gene for familial polyposis coli maps to the long arm of chromosome 5. Science (80) 238
(4832), 1411–1413.
Marqués-Lespier, J.M., Diaz-Algorri, Y., Gonzalez-Pons, M., Cruz-Correa, M., 2014. Report of a
novel mutation in MLH1 gene in a Hispanic family from Puerto Rico fulfilling classic Amster-
dam criteria for lynch syndrome. Gastroenterol. Res. Pract. 2014.
Merg, A., Lynch, H.T., Lynch, J.F., Howe, J.R., 2005. Hereditary colon cancer--part I. Curr. Prob.
Surg. 42 (4), 195–256.
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S., et al., 1994.
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266
(5182), 66–71.
Milne, R.L., Osorio, A., Cajal, T.R.Y., Vega, A., Llort, G., De La Hoya, M., et al., 2008. The average
cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2
attending genetic counseling units in Spain. Clin. Cancer Res. 14 (9), 2861–2869.